Paper from the BMJ by Higgins J. P. T. et al Reviews have recently started including the quantity I 2 to help readers assess the of the results of studies in meta-analyses. What does this new quantity mean, and why is of heterogeneity so important to clinical practice?
No takes yet. Share an insight, caveat, or question.
Higgins et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: